0001946439-24-000002.txt : 20240216 0001946439-24-000002.hdr.sgml : 20240216 20240216163042 ACCESSION NUMBER: 0001946439-24-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240214 FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davis Krista CENTRAL INDEX KEY: 0001946439 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31812 FILM NUMBER: 24648871 MAIL ADDRESS: STREET 1: C/O ANI PHARMACEUTICALS, INC. STREET 2: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001023024 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 582301143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 BUSINESS PHONE: 2186343500 MAIL ADDRESS: STREET 1: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 FORMER COMPANY: FORMER CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19991228 FORMER COMPANY: FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC DATE OF NAME CHANGE: 19991027 4 1 wk-form4_1708119020.xml FORM 4 X0508 4 2024-02-14 0 0001023024 ANI PHARMACEUTICALS INC ANIP 0001946439 Davis Krista C/O ANI PHARMACEUTICALS, INC. 210 MAIN STREET WEST BAUDETTE MN 56623 0 1 0 0 SVP, CHIEF HR OFFICER 0 Common Stock 2024-02-14 4 A 0 12079 0 A 44666 D Common Stock 2024-02-14 4 A 0 8052 0 A 52718 D Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 14, 2024. These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. /s/ Krista Davis, by attorney-in-fact Meredith W. Cook 2024-02-16